Philips, World Bank, and Ukraine Ministry of Health announce successful deployment of nationwide acute stroke care upgrade, helping thousands of patients
10 Fevereiro 2025 - 6:00AM
February 10, 2025
Groundbreaking program that provides technology and training is
reducing the impact of stroke, one of the leading causes of death
and disability, by establishing an advanced nationwide acute stroke
treatment network
Amsterdam, the Netherlands and Kyiv, Ukraine –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health
technology, in collaboration with the World Bank and Ukraine’s
Ministry of Health (MOH), today announced a nationwide initiative
to modernize stroke and cardiovascular care in Ukraine. The demand
for stroke care in Ukraine is nearly doubling, exacerbated by war
damage and displaced populations lacking access to timely care.
This program – which is already well on its way – aims to address
these immense challenges by creating an advanced network of
locations for the diagnosis and treatment of stroke.
The joint initiative delivers advanced image-guided therapy
systems optimized for acute stroke treatment to key regions,
including Dnipro, Sumy, Kharkiv, Lviv, Zaporizhzha and Odesa.
Philips is deploying 25 of its Azurion interventional suites to
support minimally invasive stroke treatments. These systems support
complex neurovascular procedures, such as thrombectomies*, which
can reverse stroke effects. The systems integrate software tools
and technologies to accelerate procedures and enhance care
coordination. Together, these innovations streamline care pathways,
reduce treatment delays and improve patient outcomes. Philips is
working with its partner, AFS Medizintechnik, to roll out systems
across the country. So far, 19 systems have been installed and are
already helping Ukrainian physicians provide optimized care to
their stroke patients.
“Every year, approximately 140,000 Ukrainians experience a
stroke, with many facing disability or death due to delayed
treatment,” said Carla Goulart Peron, Chief Medical Officer at
Philips. “This collaboration ensures patients in underserved
regions gain access to life-saving technologies.”
“This program is saving lives, reducing disability, and changing
the futures of stroke patients,” said Dr. Dmytro Lebedynets, a
neurologist at Feofaniya Clinical Hospital and consultant on stroke
to the World Bank and the Ministry of Health of Ukraine. “With
these advanced tools, we can deliver timely and precise life-saving
care, even in emergencies. It’s a game-changer for our patients.
Now all the regions of our country will be able to provide the full
spectrum of care to stroke patients.”
Comprehensive trainingThe program also
emphasizes comprehensive clinical training to ensure the new stroke
network is utilized to its full potential. As part of the
initiative, physicians will undergo hands-on education and training
in Poland. This approach guarantees the latest expertise in stroke
treatment , enabling consistent high-quality care delivery across
Ukraine.
Partnering with World Stroke
OrganizationPhilips’ ongoing partnership with the World
Stroke Organization, established in 2023, has been further expanded
through its involvement in the WSO Advocacy Coalition, becoming
part of a global network that actively works on healthcare policy,
raises public awareness, and advocates for increased investment in
stroke care infrastructure.
* A thrombectomy is a minimally invasive procedure where doctors
use a small device called a catheter to remove a blood clot from a
blood vessel, restoring normal blood flow and preventing damage to
vital organs like the brain.
For further information, please contact:
Joost MalthaPhilips Global External RelationsTel.: +31 6 10 55
8116E-mail : joost.maltha@philips.com
About Royal PhilipsRoyal Philips (NYSE: PHG,
AEX: PHIA) is a leading health technology company focused on
improving people's health and well-being through meaningful
innovation. Philips’ patient- and people-centric innovation
leverages advanced technology and deep clinical and consumer
insights to deliver personal health solutions for consumers and
professional health solutions for healthcare providers and their
patients in the hospital and the home. Headquartered in the
Netherlands, the company is a leader in diagnostic imaging,
ultrasound, image-guided therapy, monitoring and enterprise
informatics, as well as in personal health. Philips generated 2023
sales of EUR 18.2 billion and employs approximately 69,300
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
- Philips angiosuite
- Mechanic 1
- Mechanic 2
- Unloading angiosuite
Koninklijke Philips NV (NYSE:PHG)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Koninklijke Philips NV (NYSE:PHG)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025
